Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn

Japanese Journal of Ophthalmology

Volumn 47, Issue 5, 2003, Pages 423-426

  Sakimoto, Tohru ^a   Shoji, Jun ^a   Sawa, Mitsuru ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basement membrane; Gelatinase; Matrix metalloproteinase; Ulceration; Zymography

Indexed keywords

BUFFER; GELATIN; GELATINASE; GELATINASE A; GELATINASE B; PHOSPHATE; SODIUM CHLORIDE;

ARTICLE; CONTROLLED STUDY; CORNEA ULCER; DISEASE SEVERITY; ELUTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXTRACTION; EYE BURN; EYE DISEASE; EYE INFECTION; HERPES SIMPLEX KERATITIS; HUMAN; LACRIMAL FLUID; PERFORATING EYE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE; SCHIRMER TEST; ZYMOGRAPHY;

EID: 0042837891     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(03)00138-2     Document Type: Article

References (18)

1. Fang J., Shing Y., Wiederschain D., et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA. 97:2000;3884-3889.
2. Hrabec E., Strek M., Nowak D., et al. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas. J Cancer Res Clin Oncol. 128:2002;197-204.
3. Onisto M., Garbisa S., Caenazzo C., et al. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinase and inhibitors involved in tumor matrix invasion. Diagn Mol Pathol. 2:1993;74-80.
4. Polette M., Nawrocki B., Gilles C., et al. MT-MMP expression and localization in human lung and breast cancers. Virchows Arch. 428:1996;29-35.
5. Hasty K.A., Reife R.A., Kang A.H., et al. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum. 33:1990;388-397.
6. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 378:1997;151-160.
7. Atkinson S.J., Crabbe T., Cowell S., et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem. 270:1995;30479-30485.
8. Matsubara M., Zieske J.D., Fini M.E. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 32:1991;3221-3237.
9. Smith V.A., Hoh H.B., Easty D.L. Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol. 83:1999;1376-1383.
10. Smith V.A., Rishmawi H., Hussein H., Easty D.L. Tear film MMP accumulation and corneal disease. Br J Ophthalmol. 85:2001;147-153.
11. Roper-Hall M.J. Thermal and chemical burns. Trans Ophthalmol Soc UK. 85:1965;631-653.
12. Klyce S.D., Beuerman R.W. Structure and function of the cornea. Kaufman H.E. The cornea. 2nd ed:1998;3-50 Butterworth-Heinemann, Boston.
13. Giannelli G., Falk-Marzillier J., Schiraldi O., et al. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science. 277:1997;225-228.
14. Fini M.E., Parks W.C., Rinehart W.B., et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol. 149:1996;1287-1302.
15. Azar D.T., Hahn T.W., Jain S., et al. Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 15:1996;18-24.
16. Sobrin L., Liu Z., Monroy D.C., et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 41:2000;1703-1709.
17. Kosaku K., Maeda N., Yokoyama T., et al. Effect of matrix metalloproteinase inhibitor on experimental pseudomonal corneal ulceration. Nippon Ganka Gakkai Zashi (J Jpn Ophthalmol Soc). 102:1998;717-723.
18. Kumagai N., Yamamoto K., Fukuda K., et al. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol. 110:2002;489-491.